|
1
|
Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
|
J Am Soc Nephrol
|
2004
|
1.44
|
|
2
|
Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients.
|
Am J Kidney Dis
|
2005
|
1.15
|
|
3
|
Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice.
|
Circulation
|
2005
|
1.14
|
|
4
|
Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers.
|
Kidney Int
|
2004
|
0.95
|
|
5
|
Dietary salt restriction accelerates atherosclerosis in apolipoprotein E-deficient mice.
|
Atherosclerosis
|
2005
|
0.92
|
|
6
|
Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure.
|
J Urol
|
2008
|
0.90
|
|
7
|
[Continued late referral of patients with chronic kidney disease. Causes, consequences, and approaches to improvement].
|
Presse Med
|
2006
|
0.85
|
|
8
|
Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
|
Nephrol Dial Transplant
|
2007
|
0.84
|
|
9
|
Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profile.
|
Blood Purif
|
2008
|
0.75
|